Meltem Baykara

14PUBLICATIONS
160CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesMolecular targetsWomen's studies (incl. girls' studies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 26, 2026
Functional Mobility as a Prognostic Marker in Geriatric Oncology: A Prospective Study Using Gait Speed.

|Jul 15, 2026
Real-World Outcomes and Prognostic Factors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Multicenter Study.

|May 27, 2026
Prognostic Value of the Prognostic Nutritional Index in Patients with Locally Advanced Bladder Cancer Receiving Perioperative Chemotherapy: A Multicenter Real-World Study.

|May 27, 2026
Does the Duration of FLOT Infusion Change the Outcome of Perioperative Treatment for Gastric Cancer? Comparing 24- and 48-h Infusions.

|May 08, 2026
Comparison of flat-dose versus weight-based dose nivolumab treatment in NSCLC patients.

|Apr 14, 2026
Baseline vitamin D status and clinical outcomes in advanced non-small cell lung cancer patients treated with nivolumab.

Gözde Ağdaş, Duygu Bayir, Elif Şahin

Pageof 3

Frequent Collaborators

8 joint publications

Beyza Ünlü

6 joint publications

Yaşar Culha

5 joint publications

Hacer Demir

4 joint publications

Duygu Ozaskın